Immune response to three doses of mRNA SARS-CoV-2 vaccines in CD19-targeted chimeric antigen receptor T cell immunotherapy recipients.
Cancer Cell
; 40(3): 236-237, 2022 03 14.
Article
in En
| MEDLINE
| ID: mdl-35093212
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
T-Lymphocytes
/
Immunotherapy, Adoptive
/
Antigens, CD19
/
Receptors, Chimeric Antigen
/
COVID-19 Vaccines
/
SARS-CoV-2
/
COVID-19
Type of study:
Observational_studies
Limits:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Cancer Cell
Journal subject:
NEOPLASIAS
Year:
2022
Document type:
Article
Affiliation country:
Country of publication: